Impact of Topical 0.05% Cyclosporine A Eye Drops on Post–Femtosecond-Assisted Laser In Situ Keratomileusis Ocular Surface Recovery: A Randomized Clinical Trial

Lu Zhao,Hongyu Duan,Baikai Ma,Tingting Yang,Yifan Zhou,Yilin Liu,Jiawei Chen,Yueguo Chen,Hong Qi
DOI: https://doi.org/10.1097/icl.0000000000001103
2024-07-26
Eye & Contact Lens Science & Clinical Practice
Abstract:Femtosecond-assisted laser in situ keratomileusis (FS-LASIK) is one of the most common refractive surgeries. It involves the creation of a corneal flap using a femtosecond laser, followed by excimer laser ablation of the stromal layer. The cutting of subbasal nerve fibers and the release of inflammatory mediators caused by laser application are both related to postoperative dry eye disease (DED). 1 Postoperative DED affects approximately 94.8% of patients at 1 day, 85.4% at 1 week, and 59.4% at 1 month. 2 While DED typically manifests transiently in the early postoperative period, it can progress and develop into a chronic condition. Approximately 8% to 20% of patients experience chronic DED for more than 6 months, 3–5 leading to significant patient dissatisfaction and discomfort.
ophthalmology
What problem does this paper attempt to address?